E
Health Catalyst, Inc. HCAT
$1.10 -$0.12-9.50% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Health Catalyst, Inc. is a healthcare data and analytics company that provides technology and professional services designed to help healthcare organizations improve clinical, financial, and operational performance. The company operates primarily in the healthcare information technology and data analytics industries, with a focus on hospitals, health systems, and academic medical centers. Its core offering centers on aggregating and analyzing large volumes of healthcare data to support value-based care, quality improvement, and cost management initiatives.

The company generates revenue primarily through subscription-based software licenses, cloud-hosted data platform access, and professional services. Health Catalyst differentiates itself through an integrated analytics platform, deep domain expertise in healthcare delivery, and a long-standing emphasis on outcomes improvement rather than standalone reporting tools. Founded in 2008, the company grew out of collaborative work with U.S. health systems seeking to better leverage clinical and financial data, and it became a publicly traded company in 2019 following its initial public offering.

Business Operations

Health Catalyst operates through two primary business segments: Technology and Professional Services. The Technology segment includes subscription revenue from its cloud-based data platform and analytics applications, which integrate clinical, financial, and operational data from disparate source systems. The Professional Services segment provides implementation, analytics enablement, improvement consulting, and managed services that support customers in adopting and operationalizing the technology.

Operations are primarily focused in the United States, though the company serves select international customers. Health Catalyst’s core technology assets include its enterprise data platform, analytics applications, and data management tools, which are typically deployed in cloud environments. The company also maintains subsidiaries that support software development, services delivery, and customer engagement, with its offerings often sold directly to healthcare provider organizations rather than through channel partners.

Strategic Position & Investments

Health Catalyst’s strategy centers on supporting the transition to value-based care by enabling data-driven decision-making and measurable improvement in outcomes. Growth initiatives have included expanding its application portfolio, enhancing data platform capabilities, and increasing recurring subscription revenue as a proportion of total revenue. The company has pursued selective acquisitions to broaden its analytics, interoperability, and improvement science capabilities, integrating acquired technologies into its core platform.

Notable acquisitions over time have included Able Health, Healthfinch, and Twistle, each aimed at strengthening data exchange, automation, and patient engagement functionality. Health Catalyst has also invested in emerging areas such as cloud-native analytics, interoperability standards, and advanced data management to maintain relevance as healthcare data complexity increases. While the company has explored adjacent markets and technologies, public disclosures indicate a continued primary focus on healthcare provider analytics rather than diversification outside healthcare.

Geographic Footprint

Health Catalyst is headquartered in Salt Lake City, Utah, and conducts the majority of its business in North America, particularly across the United States healthcare provider market. Its customer base includes large integrated delivery networks, regional health systems, and academic medical centers spread across multiple U.S. regions.

Internationally, the company has maintained a limited but notable presence, with operations and customers in select markets outside the U.S. These international activities have historically represented a smaller portion of total revenue, and public disclosures emphasize the U.S. as the company’s principal market. The company’s operational footprint also includes distributed employees supporting engineering, services, and customer success functions.

Leadership & Governance

Health Catalyst was co-founded by Dale Sanders, who played a significant role in shaping the company’s early vision around healthcare analytics and outcomes improvement. The leadership team emphasizes a mission-driven approach focused on measurable healthcare improvement, data transparency, and long-term customer partnerships.

Key executives include:

  • Dan BurtonChief Executive Officer
  • Jason AlgerChief Operating Officer
  • Bryan HuntChief Financial Officer
  • Steve BarlowChief Technology Officer
  • Linda LlewelynChief People Officer

The company is governed by a board of directors that includes executives and independent directors with backgrounds in healthcare, technology, and finance. Leadership communications consistently highlight disciplined growth, platform scalability, and alignment with evolving healthcare reimbursement and quality models.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $175.20
B
AAPL NASDAQ $251.64
B
MSFT NASDAQ $372.64
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.05
B
Top Financial Stocks
See All »
B
B
JPM NYSE $292.40
B
V NYSE $303.88
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.44
Top Health Care Stocks
See All »
B
LLY NYSE $903.00
B
JNJ NYSE $235.27
B
AMGN NASDAQ $348.43
Top Real Estate Stocks
See All »
B
PLD NYSE $130.35